Objective assessment of psoriasis erythema for PASI scoring
- PMID: 19639508
- DOI: 10.1080/07434610902744074
Objective assessment of psoriasis erythema for PASI scoring
Abstract
Skin colour is vital information in dermatological diagnosis as it reflects the pathological condition beneath the skin. It is commonly used to indicate the extent of diseases such as psoriasis, which is indicated by the appearance of red plaques. Although there is no cure for psoriasis, there are many treatment modalities to help control the disease. To evaluate treatment efficacy, the current gold standard method, PASI (Psoriasis Area and Severity Index), is used to determine severity of psoriasis lesion. Erythema (redness) is one parameter in PASI and this condition is assessed visually, thus leading to subjective and inconsistent results. Current methods or instruments that assess erythema have limitations, such as being able to measure erythema well for low pigmented skin (fair skin) but not for highly pigmented skin (dark skin) or vice versa. In this work, we proposed an objective assessment of psoriasis erythema for PASI scoring for different (low to highly pigmented) skin types. The colour of psoriasis lesions are initially obtained by using a chromameter giving the values L*, a*, and b* of CIELAB colour space. The L* value is used to classify skin into three categories: low, medium and highly pigmented skin. The lightness difference (DeltaL*), hue difference (Deltah(ab)), chroma (DeltaC*(ab)) between lesions and the surrounding normal skin are calculated and analysed. It is found that the erythema score of a lesion can be distinguished by their Deltah(ab) value within a particular skin type group. References of lesion with different scores are obtained from the selected lesions by two dermatologists. Results based on 38 lesions from 22 patients with various level of skin pigmentation show that PASI erythema score for different skin types i.e. low (fair skin) to highly pigmented (dark skin) skin types can be determined objectively and consistent with dermatology scoring.
Similar articles
-
Area assessment of psoriasis lesions for PASI scoring.J Med Eng Technol. 2009;33(6):426-36. doi: 10.1080/07434610902744066. J Med Eng Technol. 2009. PMID: 19557605
-
Objective assessment of psoriasis erythema for PASI scoring.Annu Int Conf IEEE Eng Med Biol Soc. 2008;2008:4070-3. doi: 10.1109/IEMBS.2008.4650103. Annu Int Conf IEEE Eng Med Biol Soc. 2008. PMID: 19163606
-
Computerized quantification of psoriasis lesions with colour calibration: preliminary results.Clin Exp Dermatol. 2009 Oct;34(7):830-3. doi: 10.1111/j.1365-2230.2008.03169.x. Epub 2009 Apr 27. Clin Exp Dermatol. 2009. PMID: 19438532
-
Scoring and monitoring the severity of psoriasis. What is the preferred method? What is the ideal method? Is PASI passé? facts and controversies.Clin Dermatol. 2010 Jan-Feb;28(1):67-72. doi: 10.1016/j.clindermatol.2009.03.001. Clin Dermatol. 2010. PMID: 20082954 Review.
-
Assessment of disease progress in psoriasis.Arch Dermatol. 1989 Feb;125(2):235-40. Arch Dermatol. 1989. PMID: 2643928 Review.
Cited by
-
Predicting psoriasis using routine laboratory tests with random forest.PLoS One. 2021 Oct 19;16(10):e0258768. doi: 10.1371/journal.pone.0258768. eCollection 2021. PLoS One. 2021. PMID: 34665828 Free PMC article.
-
The reliability and validity of outcome measures for atopic dermatitis in patients with pigmented skin: A grey area.Int J Womens Dermatol. 2015 Aug 6;1(3):150-154. doi: 10.1016/j.ijwd.2015.05.002. eCollection 2015 Aug. Int J Womens Dermatol. 2015. PMID: 28491979 Free PMC article.
-
Evaluation of the Role of Faecal Calprotectin in the Management of Psoriatic Patients under Treatment with Biologic Drugs.Biomedicines. 2022 Nov 18;10(11):2968. doi: 10.3390/biomedicines10112968. Biomedicines. 2022. PMID: 36428539 Free PMC article.
-
Artificial Intelligence-Based Psoriasis Severity Assessment: Real-world Study and Application.J Med Internet Res. 2023 Mar 16;25:e44932. doi: 10.2196/44932. J Med Internet Res. 2023. PMID: 36927843 Free PMC article.
-
Psoriasis severity classification based on adaptive multi-scale features for multi-severity disease.Sci Rep. 2023 Oct 13;13(1):17331. doi: 10.1038/s41598-023-44478-9. Sci Rep. 2023. PMID: 37833444 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical